Company profile
Foli Bio company profile
Foli Bio is a precision medicine company transforming gastrointestinal disease diagnosis and drug development through Foli-seq, a novel non-invasive gut transcriptomics platform. By decoding exfoliated human RNA from stool, Foli-seq delivers deep mechanistic insight into inflammation, barrier dysfunction and treatment response. We are building a scalable insight engine that not only powers our internal diagnostic programs and partnered biomarker discovery across pharma pipelines but also serves as the foundation for AI-driven prediction, stratification, and patient monitoring. Ultimately, Foli-seq is positioned to evolve into a domain-specific foundation model for gut diseases.
Business identity
- Website
- https://www.foli.bio/
- Contact email
- [email protected]
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 1-10 employees
- Founded
- 2023-01-01, Year
Headquarters
- Headquarters
- New York City, New York, United States
- Postal code
- 11101
- Country code
- US
- Continent
- North America